Washington Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Washington Capital Management's RGEN Position: Q1 2026 in Review
Washington Capital Management increased its Repligen (RGEN) stake by 56% in Q1 2026, buying an estimated $221K and bringing the position to 4,380 shares worth $516K. The position accounts for 0.44% of the portfolio, ranked #78.
Washington Capital Management first reported a position in RGEN in Q3 2025 and has held it in 3 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Washington Capital Management held 4,380 shares of Repligen worth $516K as of Q1 2026.
- Washington Capital Management bought 1,580 Repligen shares in Q1 2026, an estimated $221K.
- Repligen made up 0.44% of Washington Capital Management's portfolio in Q1 2026, its #78 holding.
- Washington Capital Management first reported a position in Repligen in Q3 2025 and has held it in 3 quarters since.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Washington Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.